Valneva SE VALN 深 滬
等待開盤 10-17 09:30:00 美东时间
10.29
-0.210
-2.00%
華盛通- 最 高10.55
- 今 開10.55
- 成交量 5729股
- 最 低 10.29
- 昨 收 10.50
- 總市值 8.75亿
- 52周最高 12.25
- 市盈率 靜 --
- 換手率 0.01%
- 52周最低 3.62
- 委 比 85.71%
- 總股本 8503.19万
- 歷史最高 67.84
- 量 比 0.18
- 振 幅 2.48%
- 歷史最低 3.62
- 每 手 1
- 風險率 1.95%
個股概要
財務分析
公司資料
相關新聞
分紅派息
- 分時圖
- 日k
- 周k
- 月k
相關新聞
更多First locally-acquired chikungunya case reported in U.S. since 2019
A person in Nassau County, New York, has tested positive for the chikungunya virus, a case state health officials confirmed as the first locally acquired incidence of the mosquito-borne disease in the...
10-16 01:46
Valneva Secures $500 Million Financing to Bolster Vaccine Pipeline
Valneva ( ($VALN) ) has provided an announcement. On October 6, 2025, Valneva S...
10-07 01:17
Valneva Reports Long-lasting Antibody Persistence for Chikungunya Vaccine
The latest announcement is out from Valneva ( ($VALN) ). On September 30, 2025,...
10-07 00:28
Valneva's IXCHIQ Shows 95% Antibody Seroresponse Sustained Four Years After Single Dose In Adults Aged 18 To 65+
Long-lasting antibody persistence was comparable in older (65+) and younger adultsLong-term antibody persistence is a key competitive advantage for a vaccine targeting unpredictable outbreak diseases like chikungunya
09-30 13:25
Guggenheim Maintains Buy on Valneva, Lowers Price Target to $13
Guggenheim analyst Vamil Divan maintains Valneva (NASDAQ:VALN) with a Buy and lowers the price target from $14 to $13.
09-08 21:51
Valneva Reports Positive Phase 2 Results for Lyme Disease Vaccine
Valneva ( ($VALN) ) just unveiled an update. Valneva SE announced positive resu...
09-03 20:48
Canopy Growth, Nvidia And Other Big Stocks Moving Lower In Tuesday's Pre-Market Session
U.S. stock futures were lower this morning, with the Dow futures falling around...
09-02 20:00
EHang, Molecular Partners And Other Big Stocks Moving Lower In Tuesday's Pre-Market Session
U.S. stock futures were lower this morning, with the Dow futures falling around...
08-26 20:08
美股大行评级 | 潜在涨幅17.9%！Stifel维持英伟达"买入"评级，目标价升至212美元；美银首予Figma"中性"评级，目标价85美元
今日重点评级关注：Stifel：维持英伟达"买入"评级，目标价从202美元升至212美元；蒙特利尔银行：维持Sabra Health Care REIT"与大市齐平"评级，目标价从19美元升至22美元
08-26 10:29
欧洲股市下跌 风能板块遭美国监管阻力打击
欧洲股市下跌，风能相关股票领跌，此前Orsted A/S在美国的一个项目被叫停。法国股市则因总理贝鲁呼吁进行信任投票而走低。 斯托克欧洲600指数收盘下...
08-26 00:37
